Popular weight loss drugs linked to rare but severe stomach ... - NBC News
People who take popular drugs for weight loss, such as Ozempic or Wegovy, may be at an increased risk of severe stomach problems, research published Thursday in the Journal of the American...
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
On Thursday, ahead of the diabetes conference, Denmark-based biotech firm Zealand Pharma released data that showed a high dose of its experimental weight loss drug petrelintide helped reduce...
Ozempic side effects could lead to hospitalization - CBS News
Jul 12, 2023 · Novo Nordisk, the maker of Ozempic and Wegovy, told CBS News that the drugs "are a well-established class of medicines, which have demonstrated long-term safety in clinical trials.
Ozempic and Wegovy weight loss drugs are life changers, for ... - NBC News
Feb 2, 2023 · Demand for weight loss drugs has soared over the last year, to the point that semaglutide — better known by the brand names Ozempic and Wegovy — has been in short supply at pharmacies ...
Ozempic weight loss: Jabs could slow ageing, researchers say
Aug 31, 2024 · New studies suggest the weight loss drug could be used to treat a range of issues, including heart failure.
Popular use of obesity drugs like Ozempic could change ... - CBS News
Oct 20, 2023 · Increased adoption of weight loss drugs will likely shift demand patterns, as opposed to universally suppress consumption.
What to Know About Ozempic and Other Drugs Used for Weight Loss …
May 20, 2024 · News around drugs like Ozempic moves fast: There’s a steady drumbeat of new studies, new regulatory approvals, new shortages, new insurance hurdles.
FDA updates Ozempic label with potential blocked intestines ... - CBS News
Sep 28, 2023 · The label for the diabetes drug Ozempic — which has become popular for weight loss — now acknowledges reports of blocked intestines following use of the medication. The change comes after the...
Ozempic Pill? What To Know About New Weight-Loss Drugs In …
Jun 29, 2023 · A phase 3 trial of Novo Nordisk's oral semaglutide in people who are obese or overweight and do not have Type 2 diabetes found that the average participant lost 15% of their body weight after 68...
Weight-loss drugs replacing some surgeries, but doctors say …
1 day ago · The U.S. Food and Drug Administration approved the drugs for weight loss in 2021. The drugs, called glucagon-like peptide-1 receptor agonists, or GLP-1 RAs, have helped some patients lose an ...